Table 2 Differentially expressed genes between tCLL and oCLL with known relevant roles in CLL.

From: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

Gene symbol

Expression rank

Log2 fold change

p-adjusted

tCLL

oCLL

B cells

tCLL vs. oCLL

tCLL vs. B cells

oCLL vs. B cells

tCLL vs. oCLL

tCLL vs. B cells

oCLL vs. B cells

BCL2L11

0.78

0.88

0.93

–0.63

–1.28

–0.33

0.006

0.003

0.257

BCL3

0.92

0.82

0.91

0.92

–0.02

–0.87

<0.001

0.961

0.002

BTK

0.91

0.88

0.94

0.31

–0.50

–0.83

0.001

0.002

<0.001

CD79B

0.86

0.77

0.87

0.67

–0.05

–0.60

0.002

0.925

0.075

CD274 (PD-L1)

0.06

0.23

0.12

–1.72

–0.54

0.27

<0.001

0.203

0.278

LAG3

0.96

0.87

0.71

1.37

6.32

4.65

0.001

<0.001

<0.001

LYN

0.97

0.98

0.99

–0.32

–0.90

–0.55

0.001

<0.001

0.001

TIGIT

0.37

0.59

0.17

–1.80

2.48

4.40

<0.001

<0.001

<0.001

  1. Comparison with normal mature B cells is also shown. tCLL: CLL harboring t(14;19); oCLL: other CLL cases, without t(14;19); Expression rank: gene ranking as expression level percentile in tCLL, oCLL, and B cells: 0 =  lowest expression, 1 = highest expression.